Cargando…
Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma
BACKGROUND: Neuroblastoma (NB) is considered an immunologically cold tumor and is usually less responsive to immune checkpoint blockade (ICB). Tumor-associated macrophages (TAMs) are highly infiltrated in NB tumors and promote immune escape and resistance to ICB. Hence therapeutic strategies targeti...
Autores principales: | Rohila, Deepak, Park, In Hwan, Pham, Timothy V., Jones, Riley, Tapia, Elisabette, Liu, Kevin X., Tamayo, Pablo, Yu, Alice, Sharabi, Andrew B., Joshi, Shweta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283071/ https://www.ncbi.nlm.nih.gov/pubmed/37350973 http://dx.doi.org/10.3389/fimmu.2023.1148317 |
Ejemplares similares
-
Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
por: Rohila, Deepak, et al.
Publicado: (2023) -
Fisetin Suppresses Macrophage-Mediated Inflammatory Responses by Blockade of Src and Syk
por: Kim, Jun Ho, et al.
Publicado: (2015) -
“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
por: Liu, Kevin X., et al.
Publicado: (2020) -
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
por: Ishfaq, Mehreen, et al.
Publicado: (2021) -
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
por: Tümmler, Conny, et al.
Publicado: (2019)